ZEALAND PHARMA’s (ZEAL) Quiet Period Will Expire on September 18th

ZEALAND PHARMA’s (NASDAQ:ZEAL) quiet period will expire on Monday, September 18th. ZEALAND PHARMA had issued 4,375,000 shares in its initial public offering on August 9th. The total size of the offering was $78,181,250 based on an initial share price of $17.87. During ZEALAND PHARMA’s quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

A number of equities research analysts recently issued reports on the company. Morgan Stanley assumed coverage on ZEALAND PHARMA in a research report on Tuesday, September 5th. They issued an “overweight” rating and a $28.00 target price on the stock. Needham & Company LLC initiated coverage on ZEALAND PHARMA in a research report on Tuesday, September 5th. They set a “buy” rating and a $26.00 price target on the stock. Finally, Guggenheim initiated coverage on ZEALAND PHARMA in a research report on Tuesday, September 5th. They set a “buy” rating and a $28.00 price target on the stock.

TRADEMARK VIOLATION NOTICE: This article was published by Ticker Report and is the property of of Ticker Report. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.tickerreport.com/banking-finance/2887522/zealand-pharmas-zeal-quiet-period-will-expire-on-september-18th.html.

ZEALAND PHARMA (ZEAL) opened at 20.03 on Wednesday. The firm’s market cap is $615.32 million. ZEALAND PHARMA has a 52-week low of $16.07 and a 52-week high of $20.37. The firm’s 50 day moving average price is $18.38 and its 200 day moving average price is $18.38.

Receive News & Ratings for ZEALAND PHARMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZEALAND PHARMA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.